ANRO fundamentals
An in-depth look to Alto Neuroscience, Inc. operating, investing, and financing activities
ANRO free cash flow for Q4 24 is -13.53 M USD. For 2024, ANRO free cash flow was -49.5 M USD and operating cash flow was -47.42 M USD.
Q4 '22
Q1 '23
Q2 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM